Dr. Catherine Helmer is a physician–epidemiologist researcher at Bordeaux Population Health Inserm Center U1219. She is the scientific leader of the "Mechanisms and processes of age-related diseases" axis in the LEHA—Lifelong exposures, health and aging-team within U1219. She is particularly involved in population-based cohorts in cerebral aging; she is the co-PI of the 3C-Bordeaux study and is also co-investigator of the Biobank and Brain health in Bordeaux (B cube) cohort. She has also been deputy medical officer at Clinical Investigation Center—Clinical Epidemiology 1401 in Bordeaux “Aging Axis” since November 2007. Her research focuses on the epidemiology and the determinants of cognitive decline and dementia/Alzheimer’s disease, as well as the public health consequences of these diseases, with the aim of developing preventive interventions. Her research interests include: 1. the infectious hypothesis in the development of Alzheimer's disease; 2. the links between eye and brain aging, including ocular biomarkers of cognitive aging and dementia.
Dr. Catherine Helmer is a physician–epidemiologist researcher at Bordeaux Population Health Inserm Center U1219. She is the scientific leader of the "Mechanisms and processes of age-related diseases" axis in the LEHA—Lifelong exposures, health and aging-team within U1219. She is particularly involved in population-based cohorts in cerebral aging; she is the co-PI of the 3C-Bordeaux study and is also co-investigator of the Biobank and Brain health in Bordeaux (B cube) cohort. She has also been deputy medical officer at Clinical Investigation Center—Clinical Epidemiology 1401 in Bordeaux “Aging Axis” since November 2007. Her research focuses on the epidemiology and the determinants of cognitive decline and dementia/Alzheimer’s disease, as well as the public health consequences of these diseases, with the aim of developing preventive interventions. Her research interests include: 1. the infectious hypothesis in the development of Alzheimer's disease; 2. the links between eye and brain aging, including ocular biomarkers of cognitive aging and dementia.